Ascendis Pharma A (ASND) Current Deferred Revenue (2012 - 2026)
Ascendis Pharma A (ASND) reported Current Deferred Revenue of $2.85 million for the quarter ended Mar 31, 2026, up 292.0% from $727,904 a year earlier and up 118.3% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Current Deferred Revenue (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A posted Current Deferred Revenue of $1.27 million, down 76.6% from the prior year.
- Current Deferred Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -27.5% (years ended Dec 2020 to Dec 2025).
- By year, Current Deferred Revenue came in at $5.41 million in the year ended Dec 31, 2024 (-15.9%), $6.44 million in the year ended Dec 31, 2023 (-57.0%), $14.98 million in the year ended Dec 31, 2022 (+151.7%) and $5.95 million in the year ended Dec 31, 2021 (-6.2%).
- The figure for the quarter ended Mar 31, 2026 ranks as the highest quarterly Current Deferred Revenue since the quarter ended Dec 31, 2024.
- Year over year, Current Deferred Revenue gained in 1 of the last six quarters, with an average decline of 9.6%.
- The high point for year-over-year Current Deferred Revenue in five years was the quarter ended Mar 31, 2022 (growth of 985.8%); the low point was the quarter ended Mar 31, 2025 (a decline of 86.6%).
- Per Business Quant data, the three quarters before the quarter ended Mar 31, 2026 came in at $1.31 million (quarter ended Dec 31, 2025), $808,986 (quarter ended Sep 30, 2025) and $783,316 (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Ascendis Pharma A | 14.14 Bn | 10.38 Bn | 362.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.85 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 808,986.12 |
| Jun 30, 2025 | 783,316.10 |
| Mar 31, 2025 | 727,904.03 |
| Dec 31, 2024 | 5.34 Mn |
| Sep 30, 2024 | 5.49 Mn |
| Jun 30, 2024 | 5.38 Mn |
| Mar 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 6.40 Mn |
| Sep 30, 2023 | -10.05 Mn |
| Jun 30, 2023 | -9.93 Mn |
| Mar 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 14.50 Mn |
| Sep 30, 2022 | 13.26 Mn |
| Jun 30, 2022 | 3.95 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 5.95 Mn |
| Sep 30, 2021 | -385,626.95 |
| Jun 30, 2021 | -262,531.17 |
API Access
Ascendis Pharma A Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();